We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

EKF Introduces Specific Biomarker Test For Early Sepsis Identification

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

EKF Diagnostics has introduced the Stanbio Chemistry Procalcitonin (PCT) LiquiColor® Assay. This new test enables the quantitative determination of PCT in serum samples, EDTA or lithium heparin plasma samples by latex enhanced immunoturbidimetric methodology. Procalcitonin is a marker for bacterial infection and sepsis and has been recognized as an important adjunct marker in the diagnosis of sepsis.

The new Stanbio Chemistry Procalcitonin (PCT) LiquiColor® Assay is fast, accurate and convenient. The test provides a precise result, which correlates well with established methodology, within 10 minutes and requires just 20 µL of sample. The reagents may be used on almost any liquid-based chemistry analyzer with open-channel capability. In addition, the reagent kit, calibrator and control sets are all available separately. 

Commenting on the cost-effectiveness and convenience of the Stanbio Chemistry Procalcitonin (PCT) LiquiColor® Assay, Al Blanco, Business Unit Director – Central Laboratory at EKF Diagnostics said, “This assay can be performed on a customer’s existing chemistry analyzer with the same collection tube used for analysis of other chemistry tests.  Therefore, it will provide optimized lab workflow by eliminating the need to split a sample or have a dedicated off-line workstation. These features will provide any lab with a cost-effective solution for PCT testing.”